Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125713141 | 12571314 | 1 | I | 2009 | 20160711 | 20160719 | 20160719 | EXP | US-SA-2016SA128910 | AVENTIS | 64.00 | YR | A | F | Y | 94.34000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125713141 | 12571314 | 1 | PS | LANTUS | INSULIN GLARGINE | 1 | Unknown | U | UNKNOWN | 21081 | |||||||||
125713141 | 12571314 | 2 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125713141 | 12571314 | 2 | Blood triglycerides abnormal |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125713141 | 12571314 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125713141 | 12571314 | Blood glucose increased | |
125713141 | 12571314 | Glycosylated haemoglobin increased | |
125713141 | 12571314 | Hypoaesthesia | |
125713141 | 12571314 | Infection | |
125713141 | 12571314 | Neuropathy peripheral | |
125713141 | 12571314 | Renal disorder | |
125713141 | 12571314 | Thyroid disorder | |
125713141 | 12571314 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125713141 | 12571314 | 1 | 2009 | 2010 | 0 |